AMT-260
Uniqure
[]
it was a pleasure to share more about amt-260, our #genetherapy program in refractory temporal lobe #epilepsy (#tle), in an oral presentation today at #aan2023 right here in our boston backyard. 
uniQure is delivering on the promise of gene therapy - single treatments with potentially curative result for patients with severe genetic diseases.